Brookdale Senior Living vs Ensign
BKD and ENSG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BKD and ENSG compare
Ensign is the larger company, worth 4.4 times as much as Brookdale Senior Living ($10.9B against $2.5B).
Ensign grew revenue faster over the last twelve months (18.9% versus −4.4% for Brookdale Senior Living).
Ensign keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with −4.5% at Brookdale Senior Living.
Ensign pays a dividend yielding 0.14%; Brookdale Senior Living does not pay one.
Ensign scores higher on the StockData Score (19 against 5 for Brookdale Senior Living), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BKD | ENSG |
|---|---|---|
| Size and price | ||
| Market cap | $2.5B | $10.9B |
| Share price | $10.39 | $186.32 |
| Change, 1 year | 16.1% | 0.37% |
| Change, 5 years | 37.3% | 124% |
| Beta (5Y) | 0.67 | 0.46 |
| Employees | 33K | 46K |
| StockData Score | ||
| Total score | 5 | 19 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 5 (better) |
| Performance score | 1 | 6 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 29.2× |
| P/S | 0.8× (better) | 2.0× |
| P/B | – | 4.4× |
| EV/EBITDA | 14.8× (better) | 18.4× |
| P/FCF | 105× | – |
| PEG | – | 2.10 |
| FCF yield | 0.96% | – |
| Fair value | – | $151.76 |
| Margin of safety | – | −22.8% |
| Growth | ||
| Revenue growth (TTM) | −4.4% | 18.9% (better) |
| Revenue growth, 5Y average | −2.0% | 16.1% (better) |
| Net income growth (TTM) | – | 17.3% |
| EPS growth (TTM) | – | 15.8% |
| EPS growth, 5Y average | – | 13.8% |
| Profitability | ||
| Gross margin | 26.9% (better) | 20.7% |
| Operating margin | 3.5% | 8.5% (better) |
| Net margin | −4.5% | 6.9% (better) |
| FCF margin | 0.78% | – |
| Return on equity | −362% | 17.0% (better) |
| Return on invested capital | 2.1% | 17.7% (better) |
| Financial health | ||
| Debt / equity | – | 0.06 |
| Net debt / EBITDA | 9.04 (better) | −0.31 |
| Interest coverage | – | 60.0× |
| Current ratio | 1.14 | 1.21 (better) |
| Altman Z-score | −0.17 | 3.71 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.14% |
| Payout ratio | – | 3.9% |
| Years of dividend growth | – | 15 |
| Dividend growth, 5Y average | – | 4.5% |
| Buyback yield | – | 0.37% |
| Shareholder yield | 0.00% | 0.51% (better) |
| Ownership | ||
| Held by institutions | 114% | 90.6% |
| Held by insiders | 1.4% | 3.6% |
| Insider net buying, 12 months | – | −$13.6M |
| Short interest, % of float | 19.2% | 2.6% |
Go deeper
- BKD stock overview
- BKD income statement
- BKD valuation and score
- ENSG stock overview
- ENSG income statement
- ENSG valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.